Abstract
ObjectiveCorrelates of systemic lupus erythematosus (SLE) Responder Index (SRI) response with clinical trial end points were examined using pooled data from the Study of Belimumab in Subjects with SLE (BLISS)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have